Timeline
Avacta names Richard Hughes as non‑executive chairman
AstraZeneca wins US approval for Imfinzi in early high‑risk bladder cancer
Health & Bio Today: GSK, BSF Enterprise, Nuformix, Physiomics, SkinBioTherapeutics, Property Franchise Group
BSF Enterprise lists Lab‑Grown "T‑rex" leather handbag for auction at €500,000
Small Caps Today: IQE, MicroSalt, GreenX Metals, BSF Enterprise, DP Poland and more
Physiomics builds hantavirus translational modelling framework
SkinBioTherapeutics said it's board has now completed its investigation
Health & Bio Today: ImmuPharma narrows loss with P140 partnership push, Physiomics, ValiRx, AstraZeneca
ImmuPharma narrows loss, highlights post-period fundraise
Physiomics secures more modelling and data-science contracts
ValiRx's Cytolytix secures European patent for nanoparticle delivery
Itaconix launches deeperclean.com to market its formulated detergents
AstraZeneca says FDA extends decision date for camizestrant, allowing extra data review
Health & Bio Today: Genedrive chairman exits as Nugent joins board, Novo Nordisk, Crism, Diaceutics, CVS Group, AstraZeneca,
BSF Enterprise shares roars as investors look to 'T‑Rex Leather' auction
Ondine Biomedical reports ICU feasibility study with signals of reduced pneumonia
Tern shares rocketed after loan note deal
genedrive appoints major shareholder David Nugent as director as chairman signals exit
Cardiogeni repays £810,000 of convertible loan notes
CRISM Therapeutics launches retail offer to raise up to £100,000
ProBiotix Health signs exclusive Spain and Portugal supply deal with Bioksan
CRISM Therapeutics raises £2.5m to fund Phase 2 trial and grant pursuit
AstraZeneca wins CHMP backing for Enhertu tumour‑agnostic approval
Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca
EMV Capital commercial update spotlights XF-73 as it moves toward Phase 3
4basebio wins opDNA supply deal for Phase II immunotherapy trial
CelLBxHealth to deploy Parsortix with AdventHealth for two US clinical studies
ValiRx raises up to £1.155m to fund McGill in‑licence, Cytolytix preclinical work and animal‑health expansion
AstraZeneca secures US approval for blood pressure drug Baxfendy
Poolbeg to present POLB 001 CRS data at EHA
Health & Bio Today: Adaptix wins CE mark for Ortho350, Physiomics, IXICO, Novo Nordisk
IP Group's Enterprise Therapeutics hits primary endpoint in Phase 2 cystic fibrosis trial
4basebio launches enzymatic ssDNA platform
CelLBxHealth sets FY 2026 revenue floor at £2.1m
Physiomics launches board-led strategic review and says cash runway extends into 2027
Imaging Biometrics subsidiary Kirkstall wins grant for 'tumour on a chip'
Poolbeg Pharma wins Canadian patent for POLB 001 CRS use
GSK strikes exclusive China collab to roll out bepirovirsen
Avacta says pre|CISION releases payload faster and more selectively than approved ADCs
Abingdon Health named CDMO and manufacturer for 4TEEN4's diagnostic
Health & Bio Today: BSF Enterprise auctions T-Rex leather at Drouot, genedrive, ImmuPharma, Creo Medical, hVIVO
Fusion Antibodies shares dip after year-end trading statement
genedrive's MT-RNR1 test moved to routine use at Sussex NHS trust
BSF Enterprise to auction world's first T‑Rex Leather handbag at Drouot
The Premarket Brief: Vodafone buys out VodafoneThree, HSBC, Kodal Minerals, Plus500 ...
ImmuPharma launches IND‑enabling programme for Kapiglucagon with tranScrip
OptiBiotix bolsters working capital with sale of SkinBioTherapeutics shares
Seaport Therapeutics prices $254.9m Nasdaq IPO, London-listed PureTech gets a lift
Genflow Biosciences highlights progress with focus on R&D
More in Healthcare
Genedrive's personalised medicine receives Parliament boost
A government minister named Genedrive's newborn hearing-loss test as a live example of personalised medicine during a House of Commons committee session.